drugset / Trial / NCT05538767
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To compare the efficacy and safety of emodepside to that of albendazole (Zentel®) in participants aged 12-60, inclusive, infected with hookworm.
Timeline
- Start
- 2022-09-16
- Primary completion
- 2023-04-11
- Completion
- 2023-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Albendazole | Small molecule | 400 mg | — |
| Subject | Emodepside | Small molecule | 30 mg | — |